{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaxforr6dxnpdbax2pqohymvztke5seyebavyhi7g4d7qozqlssia",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mifj6vak5vu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiailjblwpdskpqimbnpjwvjtcbn24o4wvmuaewujsdedqegrhefsi"
    },
    "mimeType": "image/jpeg",
    "size": 416076
  },
  "path": "/news/2026-03-genetic-markers-early-follicular-lymphoma.html",
  "publishedAt": "2026-03-31T20:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Follicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rate of more than 10 years. The other 20%, however, experience a quickly recurring or a more aggressive version. Now researchers from the University of Missouri School of Medicine may have found a way to identify the patients at risk of recurrence, without the need for imaging and surveillance testing. Their paper is published in the American Journal of Clinical Oncology.",
  "title": "Study finds 10-plus genetic markers tied to early follicular lymphoma relapse"
}